Evidence map›Paper›PMID 37414766›Full record

ArticleNature communications2023

Induction of lysosomal exocytosis and biogenesis via TRPML1 activation for the treatment of uranium-induced nephrotoxicity.

Dengqin Zhong, Ruiyun Wang, Hongjing Zhang, Mengmeng Wang, Xuxia Zhang, Honghong Chen

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Uranium Isotopes: From Geosciences to Biomedical Sciences.Current environmental health reports · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV.Journal of the American Society of Nephrology : JASN · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Lysosomes' fallback strategies: more than just survival or death.Frontiers in cell and developmental biology · 2025
    Review
  18. Article
  19. Review
  20. Lysosomal CaScientific reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dengqin Zhong *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, PR China.ORCID 0000-0002-9632-5306
Ruiyun Wang *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, PR China.ORCID 0000-0002-8813-3064
Hongjing Zhang *Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, PR China.ORCID 0000-0001-9561-837X
Mengmeng WangInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, PR China.ORCID 0000-0002-3636-4370
Xuxia ZhangInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, PR China.ORCID 0000-0002-5888-4019
Honghong ChenInstitute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, PR China. hhchen@shmu.edu.cn.ORCID 0000-0001-9682-5709
Shanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uranium (U) is a well-known nephrotoxicant which forms precipitates in the lysosomes of renal proximal tubular epithelial cells (PTECs) after U-exposure at a cytotoxic dose. However, the roles of lysosomes in U decorporation and detoxification remain to be elucidated. Mucolipin transient receptor potential channel 1 (TRPML1) is a major lysosomal Ca

Indexed as

Transient Receptor Potential ChannelsUraniumAnimalsCalciumExocytosisLysosomesMaleMiceCalciumTransient Receptor Potential ChannelsUranium

Identifiers

PMID37414766
PMCPMC10326073
OpenAlexW4383374096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.